Dr. Emmely Genouw

Active

Private limited companyfounded 2023active for 3 yearsPastoriestraat 116, 8200 Brugge, BelgiumKBO/BCE: BE 0805.577.773

Summary

Dr. Emmely Genouw has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €202,189 and a net result of €114,057. Its solvency ranks better than 75% of 20,598 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).

Risk analysisFollow Report Compare

Dr. Emmely GenouwActiveChecked score 90/100

Risk analysis Report Compare

Activity

Specialist medical practice

NACE 86220

1 site

Size

€240,652total assets 2025

Equity: €202,189
Profit: €114,057

Turnover not published (micro format)

Financial health

90 Excellent Checked score 2025

Bankruptcy probabilitywithin 12 months: 0.3%

Structure

Emmely GenouwDirector

2025 accounts 14 days early

Why 90raises risk2 changes of registered office in 24 monthslowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 6.18, cash €107,068Figures for financial year 2025 (filed 17-07-2026)Show the evidence

Checked score

Score 2025

90 / 100

Excellent

Probability in this band: under 0.55%

Financially better than 85% of its sector peers (NACE 86, micro)

Every signal that counts is listed under Signals.

Financial strength · tick = 2024

Strong

Solvency 100+2

equity 84.0% of total assets

Liquidity 96+6

short-term debt 15.9% · cash 44.5%

Profitability 100=

return on assets 47.4%

Bankruptcy probability, 12 months

0.3% Very low

0%0.5%1.5%4%10%≥ 25%

About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,117 companies, NACE 86, micro)

Last 24 months 11-2024: 0.3% 12-2024: 0.3%● unchanged vs 11-2024 01-2025: 0.3%● unchanged vs 12-2024 02-2025: 0.4%▲ +0.1 percentage points vs 01-2025 03-2025: 0.4%● unchanged vs 02-2025 04-2025: 0.4%● unchanged vs 03-2025 05-2025: 0.8%▲ +0.4 percentage points vs 04-2025highest value 06-2025: 0.7%▼ -0.1 percentage points vs 05-2025 07-2025: 0.7%● unchanged vs 06-2025 08-2025: < 0.1%▼ -0.7 percentage points vs 07-2025lowest value 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: 0.4%▲ +0.4 percentage points vs 10-2025 12-2025: 0.4%● unchanged vs 11-2025 01-2026: 0.4%● unchanged vs 12-2025 02-2026: 0.4%● unchanged vs 01-2026 03-2026: 0.4%● unchanged vs 02-2026 04-2026: 0.4%● unchanged vs 03-2026 05-2026: 0.4%● unchanged vs 04-2026 06-2026: 0.4%● unchanged vs 05-2026 07-2026: 0.5%▲ +0.1 percentage points vs 06-2026 08-2026: 0.3%▼ -0.2 percentage points vs 07-2026 09-2026: 0.3%● unchanged vs 08-2026 10-2026: 0.3%● unchanged vs 09-2026

Credit of up to €18,000 on 30-day terms is acceptable

Liquidity ample (current ratio 6.18, compared with 3.89 in 2024, above the usual 1.5; short-term debt: 15.9% and cash: 44.5% of total assets), and 16% of the assets are financed with debt and provisions.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 82% on solvency, 84% on liquidity, 80% on profitability and 92% on growth.

The bankruptcy probability was computed on 24-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.

lowers riskraises riskneutral

2 changes of registered office in 24 months

Belgian Official Gazette

Sector: Human health activities (NACE 86)

KBO

Liquidity: current ratio 6.18, cash €107,068

NBB · annual accounts

Figures for financial year 2025 (filed 17-07-2026)

NBB · annual accounts

Latest accounts filed on time

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 17-07-2026, 14 days ahead of the deadline.

NBB · 2 filings

Deviation from the deadline

2025

14 days early

2024

13 days early

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 2 accounts on average 14 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.

Companies Code · seven months

Where today falls in the filing period

24-10-2026 today31-12-2026 year end31-07-2027 deadline

No strike-offs in the KBO publications

Searched since incorporation in 2023.

KBO publications · our coverage

17-07-2026 Annual accounts filedfinancial year 2025 · micro…
31-12-2025 Equity above €200,000equity €202,189 ▲129%
21-10-2025 Registered officeRegistered-office move

Key points

Positive: Equity rose in 2025from €88,131 to €202,189 ▲ 129% View
One director decidessole director in office 1 View
Total assets 20252 financial years filed €240,652 View

By topic

Financials

Financial year: 2025
Total assets: €240,652
Profit: €114,057
Solvency: 84.0%

Total assets▲ 98.2%

Net result

20242025

Go to Financials

Board & ownership

Board: 1 member

Emmely GenouwDirector

Go to Board & ownership

Timeline

Events: 6
Since: 2023
Next accounts: by 31-07-2027

18-07-2025Annual accounts filed
09-04-2025Registered office
11-09-2023Incorporation

Go to Timeline

Company details

Sites: 1

Legal form: Private limited company
Activity: Specialist medical practiceNACE 86220
Founded: 07-09-2023
Year ends: 31-12
Peppol: Reachable for e-invoices

Go to Company details

Articles of association

Provisions read: 14

Annual meeting: Third Friday of June at 20:00

Go to Articles of association

Key facts about Dr. Emmely Genouw

What is the company number of Dr. Emmely Genouw?: 0805.577.773. In Belgium the VAT number is the company number with BE in front: BE 0805.577.773.
Where is Dr. Emmely Genouw based?: The registered office is at Pastoriestraat 116, 8200 Brugge.Company details
What does Dr. Emmely Genouw do?: According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. Emmely Genouw?: Private limited company (BV).
When was Dr. Emmely Genouw founded?: On 07-09-2023.
Is Dr. Emmely Genouw still active?: Yes, Dr. Emmely Genouw is an active enterprise in the KBO register.
What is the turnover of Dr. Emmely Genouw?: Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is Dr. Emmely Genouw profitable?: In financial year 2025, Dr. Emmely Genouw made a profit of €114,057.
Where can I find the annual accounts of Dr. Emmely Genouw?: Dr. Emmely Genouw filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Emmely Genouw due?: By 31-07-2027, for financial year 2026.Timeline